Search

Search Results
Results 5921 - 5930 of 8190 for Skin Cancer
  • Drug - 15 Jul 2024
    Consumer Medicine Information (CMI) about Gilenya intended for persons living in Australia.
  • News - 3 Jul 2024
    Tampons from several brands that potentially millions of people use each month can contain toxic metals like lead, arsenic, and cadmium, a new study led by a UC Berkeley researcher has found.
  • News - 30 Jun 2024
    A new study found that eating a snack of baby carrots just three times a week significantly increased skin carotenoids in young adults.
  • Drug - 27 Jun 2024
    Consumer Medicine Information (CMI) about Itracap intended for persons living in Australia.
  • Drug - 7 Jun 2024
    Consumer Medicine Information (CMI) about Fynod intended for persons living in Australia.
  • Drug - 5 Jun 2024
    Consumer Medicine Information (CMI) about Prograf and Advagraf XL intended for persons living in Australia.
  • News - 30 May 2024
    A drug approved to treat certain autoimmune diseases and cancers successfully alleviated symptoms of a rare genetic syndrome called autoimmune polyendocrine syndrome type 1 (APS-1).
  • Drug - 28 May 2024
    Consumer Medicine Information (CMI) about Velsipity intended for persons living in Australia.
  • Drug - 23 May 2024
    Consumer Medicine Information (CMI) about Kisqali intended for persons living in Australia.
  • Drug - 21 May 2024
    Consumer Medicine Information (CMI) about Azacitidine-Teva intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.